Founder of Mereo BioPharma Group Plc, Denise Vera Scots-Knight occupies the position of Managing Partner at Phase4 Partners Ltd. and Chief Executive Officer & Director at Mereo BioPharma Group Plc, President at OncoMed Pharmaceuticals, Inc. (a subsidiary of Mereo BioPharma Group Plc).

She is also on the board of 5 other companies.

In the past she held the position of Managing Partner at Phase4 Partners Ltd., Chairman-Supervisory Board for Nabriva Therapeutics GmbH, Managing Director at Nomura International Plc and Member of Rothschild Asset Management Ltd.

She received a doctorate and an undergraduate degree from the University of Birmingham and an undergraduate degree from the University of California, Berkeley.